Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,453 | 49,771 | 53,514 | 62,397 | 59,763 |
| Receivables | 47,235 | 53,568 | 38,512 | 36,698 | 32,336 |
| Inventories | 67,814 | 76,842 | 61,264 | 39,617 | 41,993 |
| TOTAL | $210,597 | $192,807 | $162,190 | $144,761 | $139,053 |
| Non-Current Assets | |||||
| PPE Net | 44,858 | 43,214 | 31,120 | 30,567 | 29,995 |
| Intangibles | 190,433 | 198,819 | 197,383 | 149,484 | 77,750 |
| Other Non-Current Assets | 17,209 | 14,882 | 14,568 | 666 | 4,579 |
| TOTAL | $252,500 | $256,915 | $243,071 | $180,717 | $112,324 |
| Total Assets | $463,097 | $449,722 | $405,261 | $325,478 | $251,377 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 5,250 |
| Accounts payable and accrued liabilities | 17,759 | 11,701 | 11,969 | 7,238 | 6,260 |
| Accrued Expenses | 18,839 | 21,953 | 16,661 | 7,938 | 9,195 |
| Other current liabilities | 10,667 | 638 | 13,219 | N/A | N/A |
| TOTAL | $57,951 | $47,157 | $52,524 | $20,914 | $24,173 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,000 | 60,000 | 68,824 | 75,824 | 44,930 |
| Other Non-Current Liabilities | 11,507 | 13,208 | 32,480 | 35,251 | 3,087 |
| TOTAL | $37,085 | $74,263 | $105,108 | $113,597 | $51,786 |
| Total Liabilities | $95,036 | $121,420 | $157,632 | $134,511 | $75,959 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,828 | 43,364 | 43,076 | 42,742 | 42,403 |
| Retained earnings | 223,160 | 180,701 | 109,294 | 63,108 | 49,602 |
| Other shareholders' equity | -10,763 | 198 | -1,860 | -4,975 | -3,377 |
| TOTAL | $368,061 | $328,302 | $247,629 | $190,967 | $175,418 |
| Total Liabilities And Equity | $463,097 | $449,722 | $405,261 | $325,478 | $251,377 |